If you’re age 75 or older, you should know about PREVENTABLE. PREVENTABLE – the Pragmatic Evaluation of events And Benefits of Lipid-lowering – is a clinical trial to help researchers understand if taking a statin, a drug commonly used to lower cholesterol in younger adults, is helpful for older adults, specifically when it comes to maintaining health by preventing dementia and heart disease. “We really don’t know how these drugs work in older adults,” according to the research team at UT Health San Antonio, including Dr. Sara Espinoza, principal investigator for the local study site. “Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare.” The national study is actively ...
The CDC recently revised Body Mass Index (BMI) charts for children to help healthcare providers better track growth in children and identify “severe obesity.” Before the update, BMI charts for children did not go above 37. The revised charts extend to a BMI of 60 to account for the rise of severe obesity in children ages 2-20, according to the CDC. Now clinicians can more easily see whether a child’s BMI falls within the range of underweight, ideal weight, overweight, obese, or severely obese, based on a percentile measured against other children of the same age and gender, according to CNBC and healthline.com. A BMI higher than 95% of kids of the same age and other factors is defined as obese. Severe obesity is a BMI 120% higher than the 95th ...
Have you ever had a conversation with a doctor that left you feeling confused? These situations can be frustrating, especially when it hurts your health. Unfortunately, poor doctor-patient communication is common, even though doctors acknowledge they should avoid medical jargon when talking with patients. In a new study in JAMA Network Open, researchers surveyed 215 adults and found that when medical jargon was used by physicians, participants frequently misunderstood and often interpreted the exact opposite of what the physician intended. This confusion can lead to adverse health outcomes, according to the study. "You could be the smartest doctor in the world, yet you're useless if your patients don't understand what you are saying," Dr. Michael Pitt, study author and ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Conclusion
To eliminate cancer differences in Latino populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient advocates, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing differences. In the process, most of the speakers made ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Using Science to Address Latino Health Inconsistencies in Research
Eliseo J. Pérez-Stable, M.D., is Director of the NIMHD at the National Institutes of Health (NIH). Health Differences and Non-Medical Drivers of Health Dr. Pérez-Stable began his presentation by discussing the ways in which science can reduce differences in healthcare. First, standardized surveys, tools, and measurements are needed so that data can be combined, facilitating discovery through large data sets. Science should also be an engine for promoting variety in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Transformative Strategies in Science and Access in the US
Dr. Edith A. Perez is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic College of Medicine and the Chief Medical Officer at Bolt Biotherapeutics. Her presentation outlined strategies for health improvement as exemplified by important committees of the National Academies of Sciences, Engineering, and Medicine (NASEM) and Stand Up To Cancer (SU2C). The NASEM initiative, which was requested by congress, focuses on improving the reflectivity of people in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Leading Pathways: The Hispanic/Latino Survivorship Study
Dr. Frank Penedo is Associate Director of Cancer Survivorship & Behavioral Translational Sciences at the Sylvester Comprehensive Cancer Center at the University of Miami. The Leading Pathways Study Dr. Penedo began by presenting a summary of Leading Pathways, a Hispanic/Latino survivorship study, a collaboration between the Mays Cancer Center at UT Health San Antonio and the Sylvester Comprehensive Cancer Center at the University of Miami. The study has five key aims, the ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Novel Therapeutic Approach to Reduce Health Challenges in B-cell Acute Lymphoblastic Leukemia in Hispanic/Latino Children
Dr. Sinisa Dovat is Professor of Pediatrics, Pharmacology, and Biochemistry and Molecular Biology at Pennsylvania State University College of Medicine. He is also Four Diamond Endowed Chair and Director of Translational Research and Experimental Therapeutics in Pediatric Hematology/Oncology at Penn State University. B-Cell Acute Lymphoblastic Leukemia and Latino Children B-Cell acute lymphoblastic leukemia (B-ALL) ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Cancer Screening in Puerto Rico Challenges and Opportunities to Address Health Differences
Dr. Guillermo Tortolero-Luna is Director of the Division of Cancer Control and Population Sciences Program at the University of Puerto Rico Comprehensive Cancer Center. Cancer Statistics in Puerto Rico Dr. Tortolero-Luna began by describing the cancer landscape in Puerto Rico. In 2012, malignant cancers became the cause of death with the highest age-adjusted mortality rate in the territory. The highest cancer sites among Puerto Rican men are ...
